Related Experiment Video
Updated: Feb 8, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Association between beta-blocker use and outcomes in patients with sepsis-induced myocardial injury: An analysis
Han Wu1, Linqian Jiang2, Liman Qiu3
1Department of Anesthesiology, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, PR China.
Background:
Sepsis-induced myocardial injury (SIMI) is a severe complication with high mortality. Beta-blocker therapy in SIMI remains controversial, lacking large-sample evidence.
Objectives:
To evaluate beta-blocker impact on mortality in SIMI patients using Medical Information Mart for Intensive Care IV (MIMIC-IV) and emergency intensive care unit (eICU) databases.
Methods:
A retrospective cohort study based on MIMIC-IV (2008-2022) and eICU (2014-2015) databases included adult SIMI patients meeting Sepsis-3.0 criteria with elevated cardiac troponin. The primary exposure was beta-blocker use during ICU stay, and the primary outcome was in-hospital all-cause mortality. 1:1 propensity score matching was used to balance baseline characteristics, with multiple sensitivity analyses to verify result robustness.
Results:
MIMIC-IV included 2368 SIMI patients (1338 using beta-blockers); eICU included 3805 patients (1030 using beta-blockers). After propensity score matching (MIMIC-IV: 837/group; eICU: 902/group), beta-blocker use was associated with a significant reduction in-hospital mortality (MIMIC-IV: 19.7% vs 29.9%, OR = 0.75, 95% CI: 0.60-0.94; eICU: 28.6% vs 35.1%, OR = 0.70, 95% CI: 0.56-0.88). Long-term mortality was lower by 39% (28-day), 33% (90-day), and 27% (1-year) (all P < 0.001). Multiple sensitivity analyses confirmed robustness (E-value: 2.00-2.21). Severely ill patients (Sequential Organ Failure Assessment ≥8) had the greatest mortality reduction associated with beta-blocker use (55%). Prolonged hospital stay was consistent with a survival benefit rather than adverse effects.
Conclusion:
Beta-blocker use is associated with reduced mortality and better long-term survival in SIMI patients, requiring prospective validation.
Insights
Beta-blocker therapy in sepsis-induced myocardial injury (SIMI) significantly reduces in-hospital and long-term mortality. This large-scale study provides crucial evidence supporting beta-blocker use in SIMI patients, especially the severely ill.
Area of Science:
- Critical Care Medicine
- Cardiology
- Pharmacology
Background:
- Sepsis-induced myocardial injury (SIMI) is a critical condition associated with high mortality rates.
- The role of beta-blocker therapy in managing SIMI is not well-established due to a lack of large-scale evidence.
Purpose of the Study:
- To investigate the impact of beta-blocker administration on mortality outcomes in patients with sepsis-induced myocardial injury.
- To leverage large real-world datasets (MIMIC-IV and eICU) for robust clinical insights.
Main Methods:
- A retrospective cohort study utilizing the MIMIC-IV and eICU databases.
- Inclusion criteria: Adult patients meeting Sepsis-3.0 criteria with elevated cardiac troponin.
- Propensity score matching (1:1) and sensitivity analyses were employed to ensure result validity.
Main Results:
- Beta-blocker use was linked to a significant decrease in in-hospital mortality across both datasets post-propensity score matching.
- Long-term survival benefits were observed, with reduced 28-day, 90-day, and 1-year mortality rates.
- Severely ill patients (SOFA score ≥8) experienced the most substantial mortality reduction with beta-blocker use.
Conclusions:
- Beta-blocker therapy is associated with improved survival rates in patients suffering from sepsis-induced myocardial injury.
- The findings suggest a potential benefit of beta-blockers in SIMI, warranting further investigation through prospective clinical trials.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...

